INS and Obesity: Altogether, these experimental observations suggest that S263 phosphorylation of ACSS2 plays a crucial role in maintaining triglyceride level and in modulating insulin-induced AKT phosphorylation during obesity, thus highlighting it as a potential target in regulating glucose and lipid homeostasis.